Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09JKN
|
|||
| Drug Name |
P-BCMA-101
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1/2 | [1] | |
| Company |
Poseida Therapeutics San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03288493) P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.